WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Gentian Violet Treatment for Hidradenitis Suppurativa

Phase 2

Not yet recruiting

Conditions: Hidradenitis Suppurativa

Interventions: Drug: Gentian Violet

First Posted Date: 2020-05-14

Last Posted Date: 2024-12-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 16

Registration Number: NCT04388163

Locations: 🇺🇸
Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

RUral dispaRities in prehospitAL STEMI

Completed

Conditions: ST Elevation Myocardial Infarction
Cardiovascular Diseases

Interventions: Other: Interview
Other: No intervention
Other: Survey

First Posted Date: 2020-05-08

Last Posted Date: 2024-03-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 473

Registration Number: NCT04381260

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Appalachian Partnership to Reduce Disparities (Aim 2)

Not Applicable

Recruiting

Conditions: HCV
HIV/AIDS
STI

Interventions: Behavioral: Peer Navigation
Behavioral: mHealth

First Posted Date: 2020-05-07

Last Posted Date: 2024-02-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 141

Registration Number: NCT04378439

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Phase 2

Recruiting

Conditions: Metastatic Head-and-neck Squamous-cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Cetuximab
Other: Questionnaire administration
Other: Quality of life assessment

First Posted Date: 2020-05-05

Last Posted Date: 2024-04-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 30

Registration Number: NCT04375384

Locations: 🇺🇸
Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Food Addiction Clinical Treatment Program

Not Applicable

Completed

Conditions: Food Addiction

Interventions: Behavioral: 16-week Food Addiction Clinical Treatment (FACT) Program

First Posted Date: 2020-05-04

Last Posted Date: 2023-11-07

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 2

Registration Number: NCT04373343

Locations: 🇺🇸
Wake Forest Health Sciences, Winston-Salem, North Carolina, United States

Healthy Living Partnerships for Veterans With Migraine

Not Applicable

Not yet recruiting

Conditions: Migraine
Migraine Disorders
Migraine Without Aura
Migraine With Aura

Interventions: Behavioral: Intensive Lifestyle Intervention

First Posted Date: 2020-05-04

Last Posted Date: 2025-01-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT04373330

Stay In Treatment for Pediatric Weight Management

Recruiting

Conditions: Attrition
Pediatric Obesity
Family Research
Weight Loss

First Posted Date: 2020-04-28

Last Posted Date: 2025-01-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1100

Registration Number: NCT04364282

Locations: 🇺🇸
Children's Mercy Hospital, Kansas City, Missouri, United States
🇺🇸
Brenner Children's Hospital, Winston-Salem, North Carolina, United States

Comparing Two Types of Endometrial Activation Prior to Embryo Transfer

Not Applicable

Completed

Conditions: Infertility
Endometrial Disorder

Interventions: Procedure: Endometrial scratch with Pipelle curette
Procedure: Endometrial scratch with Shepard catheter

First Posted Date: 2020-04-27

Last Posted Date: 2022-10-20

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 195

Registration Number: NCT04363879

Nuts and Oil Pilot Study

Not Applicable

Completed

Conditions: Metabolic Syndrome

Interventions: Behavioral: Daily consumption of tree nuts and extra virgin olive oil

First Posted Date: 2020-04-24

Last Posted Date: 2023-09-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 34

Registration Number: NCT04361617

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Study of Dara-Pembro for Multiple Myeloma Patients

Phase 2

Withdrawn

Conditions: Multiple Myeloma

Interventions: Drug: Pembrolizumab

First Posted Date: 2020-04-24

Last Posted Date: 2022-04-26

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT04361851

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy